2.8K
Articles
99.5K
Citations
3.4
avg. Impact Factor
131
h-index

Most Cited Articles of Division of Medical Oncology in 2017

TitleJournalYearCitations
Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate CancerInternational Journal of Radiation Oncology Biology Physics2017419
Cancer-Associated Mutations in Endometriosis without CancerNew England Journal of Medicine2017310
Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trialAnnals of Oncology2017296
CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumoursNature Communications2017251
ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate CancerInternational Journal of Radiation Oncology Biology Physics2017166
Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: Integrated analysis of data from Study 10 and ARIEL2Gynecologic Oncology2017163
Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysisLancet Oncology, The2017156
Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypesNature Genetics2017141
Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate CancerEuropean Urology2017127
Ventricular arrhythmias and sudden death in patients taking ibrutinibBlood2017120
Scalable whole-genome single-cell library preparation without preamplificationNature Methods2017105
Survival with metastatic breast cancer based on initial presentation, de novo versus relapsedBreast Cancer Research and Treatment201792
Genetic profiling of and in diffuse large B-cell lymphoma determines cell-of-origin-specific clinical impactBlood201782
Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast CancerClinical Cancer Research201782
Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder CancerClinical Cancer Research201781
F-Fluorination of Unactivated C-H Bonds in Branched Aliphatic Amino Acids: Direct Synthesis of Oncological Positron Emission Tomography Imaging AgentsJournal of the American Chemical Society201779
The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer riskNpj Breast Cancer201778
Canadian Lung Cancer Conference 2017Current Oncology201778
CDK12 regulates alternative last exon mRNA splicing and promotes breast cancer cell invasionNucleic Acids Research201775
MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2Cancer Research201774
CLK-dependent exon recognition and conjoined gene formation revealed with a novel small molecule inhibitorNature Communications201764
Successful targeting of the NRG1 pathway indicates novel treatment strategy for metastatic cancerAnnals of Oncology201764
Real-time endoscopic Raman spectroscopy for in vivo early lung cancer detectionJournal of Biophotonics201759
A noninvasive cancer detection strategy based on gold nanoparticle surface-enhanced raman spectroscopy of urinary modified nucleosides isolated by affinity chromatographyBiosensors and Bioelectronics201758
Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label, randomised trialLancet Oncology, The201758